• 1
    Gomes I, Dale CS, Casten K et al. Hemoglobin-derived peptides as novel type of bioactive signaling molecules. AAPS J 2010; 12: 658669.
  • 2
    Fruitier-Arnaudin I, Cohen M, Bordenave S, Sannier F, Piot JM. Comparative effects of angiotensin IV and two hemorphins on angiotensin-converting enzyme activity. Peptides 2002; 23: 14651470.
  • 3
    Lantz I, Glämsta EL, Talbäck L, Nyberg F. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett 1991; 287: 3941.
  • 4
    Lee J, Mustafa T, McDowall SG et al. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase. J Pharmacol Exp Ther 2003; 305: 205211.
  • 5
    Feron D, Begu-Le Corroller A, Piot JM et al. Significant lower VVH7-like immunoreactivity serum level in diabetic patients: evidence for independence from metabolic control and three key enzymes in hemorphin metabolism, cathepsin D, ACE and DPP-IV. Peptides 2009; 30: 256261.
  • 6
    Feron D, Piot JM, Fruitier-Arnaudin I. Proteolytic degradation by cathepsin D of glycated hemoglobin from diabetes patients gives rise to hemorphin-7 peptides. Peptides 2010; 31: 956961.
  • 7
    Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 24022410.
  • 8
    Pai MP. Estimating the glomerular filtration rate in obese adult patients for drug dosing. Adv Chronic Kidney Dis 2010; 17: e53e62.
  • 9
    Cohen M, Fruitier-Arnaudin I, Sauvan R, Birnbaum D, Piot JM. Serum levels of Hemorphin-7 peptides in patients with breast cancer. Clin Chim Acta 2003; 337: 5967.
  • 10
    Dejouvencel T, Féron D, Rossignol P et al. Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2010; 30: 269275.
  • 11
    Cejka J, Zelezná B, Velek J, Zicha J, Kunes J. LVV-hemorphin-7 lowers blood pressure in spontaneously hypertensive rats: radiotelemetry study. Physiol Res 2004; 53: 603607.
  • 12
    Chagnac A, Weinstein T, Korzets A et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278: F817F822.
  • 13
    Perrot-Applanat M, Vacher S, Toullec A et al. Similar NF-?B gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies. PLoS ONE 2011; 6: e21589.
  • 14
    Taleb S, Lacasa D, Bastard JP et al. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 2005; 19: 15401542.
  • 15
    Hoffmann O, Heubner M, Anlasik T et al. Circulating 20S proteasome in patients with non-metastasized breast cancer. Anticancer Res 2011; 31: 21972201.